CL2019003595A1 - Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas. - Google Patents

Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas.

Info

Publication number
CL2019003595A1
CL2019003595A1 CL2019003595A CL2019003595A CL2019003595A1 CL 2019003595 A1 CL2019003595 A1 CL 2019003595A1 CL 2019003595 A CL2019003595 A CL 2019003595A CL 2019003595 A CL2019003595 A CL 2019003595A CL 2019003595 A1 CL2019003595 A1 CL 2019003595A1
Authority
CL
Chile
Prior art keywords
probiotic bacteria
gos
preconditioned
medium containing
containing gos
Prior art date
Application number
CL2019003595A
Other languages
English (en)
Inventor
Biljana Bogicevic
Jeroen André Muller
Nicolas Page
Guénolée Eliane Marie Prioult
Wilbert Sybesma
Thomas Sasse
Benoît Marsaux
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of CL2019003595A1 publication Critical patent/CL2019003595A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA CON COMPOSICIONES QUE COMPRENDEN GALACTO-OLIGOSACÁRIDOS (GOS) Y BACTERIAS PROBIÓTICAS QUE SE OBTIENEN MEDIANTE UN PROCESO QUE COMPRENDE LA ETAPA DE CULTIVAR LAS BACTERIAS EN UN MEDIO QUE COMPRENDE GOS; TAL COMPOSICIÓN TIENE EL EFECTO DE AUMENTAR EL EFECTO SIMBIÓTICO DE LAS BACTERIAS PROBIÓTICAS CON LOS GOS. ADEMÁS, SE CONTEMPLAN BENEFICIOS PARA LA SALUD PROPORCIONADOS POR LAS BACTERIAS PROBIÓTICAS QUE SE OBTIENEN MEDIANTE TAL PROCESO DE FERMENTACIÓN.
CL2019003595A 2017-08-04 2019-12-09 Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas. CL2019003595A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17185017 2017-08-04
EP17202142 2017-11-16

Publications (1)

Publication Number Publication Date
CL2019003595A1 true CL2019003595A1 (es) 2020-05-04

Family

ID=63168399

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003595A CL2019003595A1 (es) 2017-08-04 2019-12-09 Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas.

Country Status (10)

Country Link
US (1) US11779614B2 (es)
EP (1) EP3661371A1 (es)
CN (1) CN111372477A (es)
AU (1) AU2018310705B2 (es)
BR (1) BR112019027088A2 (es)
CL (1) CL2019003595A1 (es)
MX (1) MX2019014315A (es)
PH (1) PH12019550231A1 (es)
RU (1) RU2020108088A (es)
WO (1) WO2019025637A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230220327A1 (en) * 2019-07-01 2023-07-13 Societe Des Produits Nestle S.A. Serpin production
EP4056053A1 (en) * 2021-03-12 2022-09-14 Biogaia AB Pre-conditioning of l. reuteri
EP4056052A1 (en) * 2021-03-12 2022-09-14 Biogaia AB Gos pre-conditioning l. reuteri and gos in final formulation
EP4304388A1 (en) * 2021-03-12 2024-01-17 Société des Produits Nestlé S.A. Gos pre-conditioning lactobacillus strains and gos in final formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315266D0 (en) * 2003-06-30 2003-08-06 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2009144137A1 (en) * 2008-05-27 2009-12-03 Nestec S.A. Probiotics to improve gut microbiota
CA2760999A1 (en) * 2009-03-13 2010-09-16 Mariana Barboza Prebiotic oligosaccharides
EP2563372A4 (en) * 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
RU2624233C2 (ru) * 2011-10-18 2017-07-03 Нестек С.А. Композиция для применения при стимуляции ангиогенеза в кишечнике, всасывания питательных веществ и переносимости энтерального питания, и/или при профилактике, и/или лечении воспалительных заболеваний кишечника, и/или при выздоровлении после повреждения кишечника и хирургического вмешательства
EP3214952B1 (en) 2014-11-05 2020-04-22 Optibiotix Limited Method of producing a prebiotic composition and its use
MX2017009532A (es) * 2015-01-23 2018-04-10 Univ Temple Uso de acidos grasos de cadena corta en prevencion de cancer.

Also Published As

Publication number Publication date
RU2020108088A3 (es) 2021-12-02
CN111372477A (zh) 2020-07-03
US11779614B2 (en) 2023-10-10
AU2018310705A1 (en) 2019-11-28
BR112019027088A2 (pt) 2020-07-07
RU2020108088A (ru) 2021-08-26
MX2019014315A (es) 2020-02-03
US20210121507A1 (en) 2021-04-29
EP3661371A1 (en) 2020-06-10
WO2019025637A1 (en) 2019-02-07
AU2018310705B2 (en) 2024-01-18
PH12019550231A1 (en) 2020-07-20

Similar Documents

Publication Publication Date Title
CL2019003595A1 (es) Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas.
CO2018002709A2 (es) Composiciones no tóxicas de agente para plantas y sus procedimientos
MX2022012374A (es) Composiciones multi-suplementos.
MY188541A (en) Besifloxacin for the treatment of resistant acne
UY37069A (es) Métodos para mejorar la producción de leche mediante la administración de consorcios microbianos
CL2019002640A1 (es) Moléculas propioticas para reducir virulencia de patógenos.
CR20180175A (es) Anticuerpos anti-cd19 humano con alta afinidad
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
MX2017004890A (es) Metodos y composiciones para la generación o el mantenimiento de células pluripotentes.
CL2020003442A1 (es) Tiofenocarboxamidas sustituidas y análogos de las mismas
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
MX2020003605A (es) Manipulación del metabolismo de triptamina.
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
UY37562A (es) Cepas bacterianas, composiciones que las comprenden, plantas y semillas tratadas con éstas y métodos relacionados
CL2016002223A1 (es) Microorganismo recombinante que expresa análogos de avermectina y uso de los mismos.
CL2019002641A1 (es) Composiciones y métodos que involucran moléculas probióticas.
CO2018001615A2 (es) Fosforamidocloridato morfolino nucleósidos activados diastereoméricamente puros o sustancialmente diastereoméricamente puros y métodos para su preparación
UY34773A (es) Ácidos indanoiloxidihidrobenzofuranilacéticos como moduladores de la actividad de gpr40, composiciones que los contienen y sus usos
CL2017000540A1 (es) Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dimetilbenzofuran-3-carboxamida.
DOP2017000014A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
CO2022002066A2 (es) Métodos y composiciones para cultivar bacterias dependientes de hemoglobina
AU2016356504A8 (en) 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential
CL2016000672A1 (es) Bacteria aislada del género streptomyces
CL2015002924A1 (es) Plantas de brassica que comprenden alelos de da1 mutantes